sofosbuvir has been researched along with Viremia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 8 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, H; Fang, C; Guo, Y; Hu, S; Lan, G; Liu, Q; Nie, M; Peng, F; Peng, L; Tan, L; Xie, X; Zhang, H; Zhong, M | 1 |
| Balagopal, A; Bowden, K; Leep-Lazar, J; Quinn, J; Ribeiro, RM; Sachithanandham, J; Sulkowski, MS; Ward, K | 1 |
| Charlton, C; Hlavay, BA; Klein, MB; Ogando, N; Power, C; Stapleton, JT; Zhuo, R | 1 |
| Alloway, RR; Eckman, MH; Sherman, KE; Thakar, CV; Woodle, ES | 1 |
| Avelino-Silva, VI; Casadio, LVB; Figueiredo-Mello, C; Levin, AS; Marcilio, I; Nastri, ACSS; Ribeiro, AF; Sabino, EC | 1 |
| Alves, AMB; Andrade, MCR; Bentes, GA; Bottino, FO; Castro, MP; Fonseca, LB; Freire, MS; Gardinali, NR; Kugelmeier, T; Lima, SMB; Linhares, JHR; Lopes, CAA; Marchevsky, RS; Melgaço, JG; Miranda, EH; Moran, J; Motta, MCVA; Nudelman, RF; Oliveira, JM; Pelajo-Machado, M; Perea, JAS; Pereira, HM; Pinto, DP; Pinto, MA; Salvador Castro Faria, SB; Sarges, K; Schmidt-Chanasit, J; Silva, ACA; Silva, MCC; Silva, SA; Soares-Bezerra, RJ; Soriano, A; Souza, TML; Trindade, GF; Vilhena, LS | 1 |
| Bayer, J; Burton, J; Dodge, J; Ghobrial, M; Klein, C; Mohan, S; Niemann, CU; Rubin, RA; Terrault, NA; Trotter, J; Verna, E; Victor, D | 1 |
| Chang, JM; Chen, SC; Chiu, YW; Chuang, WL; Dai, CY; Hsieh, MY; Hsu, CT; Hsu, PY; Huang, CF; Huang, CI; Huang, JC; Huang, JF; Hung, TS; Hwang, SJ; Lee, JJ; Liang, PC; Lin, WY; Lin, YH; Liu, TW; Niu, SW; Wei, YJ; Yeh, ML; Yu, ML | 1 |
| Asrani, SK; Gonzalez-Stawinski, GV; Gottlieb, RL; Hall, SA; Joseph, SM; Lima, B; Sam, T; Trotter, JF; Wada, SY | 1 |
| Agüero, J; Alvarez, S; Ayesa, R; Cabezas, J; Calleja, JL; Chueca, N; Cobo, C; Crespo, J; Crespo-Facorro, B; Cuadrado, A; Echevarría, S; Fortea, JI; Garcia, F; Llerena, S; Lopez-Hoyos, M; Mateo, M; Pallás, JR; Pellón, R; Setién, E | 1 |
| Agarwal, K; Bruce, M; Carey, I; Spaan, M | 1 |
| Althoff, CE; Bergfeld, L; Brakemeier, S; Budde, K; Duerr, M; Eckardt, KU; Glander, P; Halleck, F; Lehner, LJ; Marticorena Garcia, SR; Sack, I; Schrezenmeier, EV | 1 |
| Eisenberger, U; Friebus-Kardash, J; Gäckler, A; Herzer, K; Kribben, A; Treckmann, J; Wedemeyer, H; Witzke, O | 1 |
| Sankawa, Y | 1 |
| Brainard, DM; Chodavarapu, K; Hedskog, C; Isakov, V; Martin, R; Miller, MD; Mo, H; Molina, JM; Sarrazin, C; Sulkowski, MS; Svarovskaia, ES | 1 |
| Abravanel, F; Bramley, P; Campbell, JD; Dalton, HR; Donnelly, MC; Fraser, AR; Hayes, PC; Imlach, SN; Johannessen, I; Kamar, N; Petrik, J; Ramalingam, S; Simpson, KJ | 1 |
4 trial(s) available for sofosbuvir and Viremia
| Article | Year |
|---|---|
Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus.
Topics: Antiviral Agents; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kinetics; Lactams, Macrocyclic; RNA, Viral; Sofosbuvir; Viremia | 2023 |
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Disease Eradication; Environmental Exposure; Female; Fluorenes; Follow-Up Studies; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Male; Middle Aged; Practice Guidelines as Topic; Prisoners; Prisons; Program Evaluation; Sofosbuvir; Spain; Sustained Virologic Response; Uridine Monophosphate; Viral Load; Viremia; Young Adult | 2018 |
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients.
Topics: Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Biopsy, Needle; Calcineurin Inhibitors; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Glucose Intolerance; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lactams, Macrocyclic; Leucine; Liver; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Pyrrolidines; Quinoxalines; RNA, Viral; Salvage Therapy; Sofosbuvir; Sulfonamides; Treatment Outcome; Valine; Viral Load; Viral Nonstructural Proteins; Viremia | 2019 |
[Complication sequelae prevented, morbidity decreased].
Topics: Carbamates; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Pyrrolidines; Sofosbuvir; Valine; Viremia | 2015 |
12 other study(ies) available for sofosbuvir and Viremia
| Article | Year |
|---|---|
Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China.
Topics: Adult; Antiviral Agents; Carbamates; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Kidney; Male; Middle Aged; Retrospective Studies; Sofosbuvir; Viremia | 2022 |
Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.
Topics: Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferons; Male; Pegivirus; Polyethylene Glycols; RNA, Viral; Sofosbuvir; Viremia | 2023 |
Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.
Topics: Adult; Antiviral Agents; Benzimidazoles; Cost-Benefit Analysis; Donor Selection; Drug Combinations; Female; Fluorenes; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Outcome and Process Assessment, Health Care; Postoperative Complications; Pyrrolidines; Quinoxalines; Sofosbuvir; Sulfonamides; Uridine Monophosphate; Viremia | 2020 |
Confronting the Multidimensional Challenges of Research in the Context of Emerging Infectious Diseases in Brazil: The Example of Yellow Fever.
Topics: Aedes; Animals; Antiviral Agents; Biomedical Research; Brazil; Communicable Diseases, Emerging; Disease Outbreaks; Government Regulation; Hospitalization; Humans; Mosquito Vectors; Patient Selection; Randomized Controlled Trials as Topic; Sofosbuvir; Viremia; Yellow Fever; Yellow fever virus | 2020 |
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Brazil; Female; Infectious Disease Transmission, Vertical; Macaca mulatta; Pregnancy; Pregnancy Complications, Infectious; Sofosbuvir; Translational Research, Biomedical; Viremia; Zika Virus; Zika Virus Infection | 2020 |
Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.
Topics: Antiviral Agents; Carbamates; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Kidney; Kidney Transplantation; Linear Models; Liver; Liver Transplantation; Male; Middle Aged; Proof of Concept Study; Prospective Studies; Sofosbuvir; Sustained Virologic Response; Tissue Donors; Transplant Recipients; Viral Load; Viremia | 2021 |
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).
Topics: Antiviral Agents; Carbamates; Drug Combinations; Hemodialysis Units, Hospital; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Mass Screening; Pilot Projects; Renal Dialysis; Seroepidemiologic Studies; Sofosbuvir; Sustained Virologic Response; Taiwan; Uremia; Viremia | 2021 |
Rational Heart Transplant From a Hepatitis C Donor: New Antiviral Weapons Conquer the Trojan Horse.
Topics: Adult; Antiviral Agents; Carbamates; Drug Combinations; Female; Heart Failure; Heart Transplantation; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Sofosbuvir; Tissue Donors; Viremia | 2017 |
The role of anti-HBs in hepatitis B reactivation during direct-acting antiviral therapy for chronic hepatitis C.
Topics: Antiviral Agents; Benzimidazoles; DNA, Viral; Female; Fluorenes; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Prospective Studies; Sofosbuvir; Viremia; Virus Activation | 2018 |
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.
Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Sofosbuvir; Sustained Virologic Response; Tissue Donors; Transplant Recipients; Viral Load; Viremia | 2019 |
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Phylogeny; Prevalence; Recurrence; Retreatment; RNA, Viral; Sequence Analysis, DNA; Sofosbuvir; Treatment Outcome; Viral Load; Viral Nonstructural Proteins; Viremia | 2017 |
Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient.
Topics: Antiviral Agents; Coinfection; Hepatitis C; HIV Infections; Humans; Sofosbuvir; T-Lymphocytes; Viremia | 2017 |